Cargando…

Stroke in mitral valve prolapse: risk factors and left atrial function in cryptogenic versus non-cryptogenic ischemic subtypes

BACKGROUND AND PURPOSE: Mitral valve prolapse (MVP) has been associated with an increased risk of ischemic stroke. Older age, thicker mitral leaflets, and significant mitral regurgitation (MR) leading to atrial fibrillation have been traditionally considered risk factors for ischemic stroke in MVP....

Descripción completa

Detalles Bibliográficos
Autores principales: Calicchio, Francesca, Lim, Lisa J., Cross, Danielle, Bibby, Dwight, Fang, Qizhi, Meisel, Karl, Schiller, Nelson B., Delling, Francesca N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408447/
https://www.ncbi.nlm.nih.gov/pubmed/37560453
http://dx.doi.org/10.3389/fneur.2023.1058697
_version_ 1785086184129560576
author Calicchio, Francesca
Lim, Lisa J.
Cross, Danielle
Bibby, Dwight
Fang, Qizhi
Meisel, Karl
Schiller, Nelson B.
Delling, Francesca N.
author_facet Calicchio, Francesca
Lim, Lisa J.
Cross, Danielle
Bibby, Dwight
Fang, Qizhi
Meisel, Karl
Schiller, Nelson B.
Delling, Francesca N.
author_sort Calicchio, Francesca
collection PubMed
description BACKGROUND AND PURPOSE: Mitral valve prolapse (MVP) has been associated with an increased risk of ischemic stroke. Older age, thicker mitral leaflets, and significant mitral regurgitation (MR) leading to atrial fibrillation have been traditionally considered risk factors for ischemic stroke in MVP. However, specific risk factors for MVP-stroke subtypes are not well defined. The aim of this study is to evaluate clinical and echocardiographic parameters, including left atrial (LA) function, in MVP with cryptogenic (C) vs. non-cryptogenic (NC) stroke. METHODS: In this case-control matched study, MVPs were identified in consecutive echocardiograms obtained after a stroke from January 2013 to December2016 at the University of California, San Francisco. MVP was defined as leaflet displacement ≥2 mm in the parasternal long-axis view at end-systole. Age/gender matched MVPs without stroke and healthy controls without MVP were also identified. We analyzed LA end-systolic/diastolic volume index, emptying fraction (LAEF), function index (LAFI), and global longitudinal strain in all MVPs and controls. We also measured left ventricular (LV) volume indexes, mass index, ejection fraction (EF), degree of MR and leaflet thickness. RESULTS: We identified a total of 30 MVPs (age 70 ± 12, 50% females) with stroke (11 with C- and 19 with NC-stroke), 20 age/gender matched MVPs without a stroke and 16 controls. MVPs without stroke had lower BMI, less hypertension but more MR (≥moderate in 45% vs. 17%), more abnormal LA function (lower LAEF, LAFI) and larger LV volumes/mass (all p < 0.05) when compared to MVPs with stroke. Leaflet thickness was overall mild (<3 mm) and similar in the 2 groups. Within the MVP stroke group, NC-stroke had higher BMI, more hypertension and more atrial fibrillation compared to C-stroke. In the variables tested, patients with C-stroke did not differ from controls. CONCLUSIONS: MVP-related MR may be protective against stroke despite abnormal LA function. Risk of NC-stroke in MVP is related to common stroke risk factors rather than mitral valve leaflet thickness. The etiology of C-stroke in MVP warrants further studies.
format Online
Article
Text
id pubmed-10408447
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104084472023-08-09 Stroke in mitral valve prolapse: risk factors and left atrial function in cryptogenic versus non-cryptogenic ischemic subtypes Calicchio, Francesca Lim, Lisa J. Cross, Danielle Bibby, Dwight Fang, Qizhi Meisel, Karl Schiller, Nelson B. Delling, Francesca N. Front Neurol Neurology BACKGROUND AND PURPOSE: Mitral valve prolapse (MVP) has been associated with an increased risk of ischemic stroke. Older age, thicker mitral leaflets, and significant mitral regurgitation (MR) leading to atrial fibrillation have been traditionally considered risk factors for ischemic stroke in MVP. However, specific risk factors for MVP-stroke subtypes are not well defined. The aim of this study is to evaluate clinical and echocardiographic parameters, including left atrial (LA) function, in MVP with cryptogenic (C) vs. non-cryptogenic (NC) stroke. METHODS: In this case-control matched study, MVPs were identified in consecutive echocardiograms obtained after a stroke from January 2013 to December2016 at the University of California, San Francisco. MVP was defined as leaflet displacement ≥2 mm in the parasternal long-axis view at end-systole. Age/gender matched MVPs without stroke and healthy controls without MVP were also identified. We analyzed LA end-systolic/diastolic volume index, emptying fraction (LAEF), function index (LAFI), and global longitudinal strain in all MVPs and controls. We also measured left ventricular (LV) volume indexes, mass index, ejection fraction (EF), degree of MR and leaflet thickness. RESULTS: We identified a total of 30 MVPs (age 70 ± 12, 50% females) with stroke (11 with C- and 19 with NC-stroke), 20 age/gender matched MVPs without a stroke and 16 controls. MVPs without stroke had lower BMI, less hypertension but more MR (≥moderate in 45% vs. 17%), more abnormal LA function (lower LAEF, LAFI) and larger LV volumes/mass (all p < 0.05) when compared to MVPs with stroke. Leaflet thickness was overall mild (<3 mm) and similar in the 2 groups. Within the MVP stroke group, NC-stroke had higher BMI, more hypertension and more atrial fibrillation compared to C-stroke. In the variables tested, patients with C-stroke did not differ from controls. CONCLUSIONS: MVP-related MR may be protective against stroke despite abnormal LA function. Risk of NC-stroke in MVP is related to common stroke risk factors rather than mitral valve leaflet thickness. The etiology of C-stroke in MVP warrants further studies. Frontiers Media S.A. 2023-07-25 /pmc/articles/PMC10408447/ /pubmed/37560453 http://dx.doi.org/10.3389/fneur.2023.1058697 Text en Copyright © 2023 Calicchio, Lim, Cross, Bibby, Fang, Meisel, Schiller and Delling. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Calicchio, Francesca
Lim, Lisa J.
Cross, Danielle
Bibby, Dwight
Fang, Qizhi
Meisel, Karl
Schiller, Nelson B.
Delling, Francesca N.
Stroke in mitral valve prolapse: risk factors and left atrial function in cryptogenic versus non-cryptogenic ischemic subtypes
title Stroke in mitral valve prolapse: risk factors and left atrial function in cryptogenic versus non-cryptogenic ischemic subtypes
title_full Stroke in mitral valve prolapse: risk factors and left atrial function in cryptogenic versus non-cryptogenic ischemic subtypes
title_fullStr Stroke in mitral valve prolapse: risk factors and left atrial function in cryptogenic versus non-cryptogenic ischemic subtypes
title_full_unstemmed Stroke in mitral valve prolapse: risk factors and left atrial function in cryptogenic versus non-cryptogenic ischemic subtypes
title_short Stroke in mitral valve prolapse: risk factors and left atrial function in cryptogenic versus non-cryptogenic ischemic subtypes
title_sort stroke in mitral valve prolapse: risk factors and left atrial function in cryptogenic versus non-cryptogenic ischemic subtypes
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408447/
https://www.ncbi.nlm.nih.gov/pubmed/37560453
http://dx.doi.org/10.3389/fneur.2023.1058697
work_keys_str_mv AT calicchiofrancesca strokeinmitralvalveprolapseriskfactorsandleftatrialfunctionincryptogenicversusnoncryptogenicischemicsubtypes
AT limlisaj strokeinmitralvalveprolapseriskfactorsandleftatrialfunctionincryptogenicversusnoncryptogenicischemicsubtypes
AT crossdanielle strokeinmitralvalveprolapseriskfactorsandleftatrialfunctionincryptogenicversusnoncryptogenicischemicsubtypes
AT bibbydwight strokeinmitralvalveprolapseriskfactorsandleftatrialfunctionincryptogenicversusnoncryptogenicischemicsubtypes
AT fangqizhi strokeinmitralvalveprolapseriskfactorsandleftatrialfunctionincryptogenicversusnoncryptogenicischemicsubtypes
AT meiselkarl strokeinmitralvalveprolapseriskfactorsandleftatrialfunctionincryptogenicversusnoncryptogenicischemicsubtypes
AT schillernelsonb strokeinmitralvalveprolapseriskfactorsandleftatrialfunctionincryptogenicversusnoncryptogenicischemicsubtypes
AT dellingfrancescan strokeinmitralvalveprolapseriskfactorsandleftatrialfunctionincryptogenicversusnoncryptogenicischemicsubtypes